ipilimumab,nivolumab
bms
['sclc', 'lcsm,(-blcsm)', 'radio', 'lonestar', 'nivo', 'ipi/', 'nsclc']
my mentor shares the outcomes of pts w/ mnsclc who had radiographic progression on 1l ipi/nivo #asco22 #lcsm #lonestar 1 resistance in 37% pts -49% of pts no subsequent tx
-22% continued i+n beyond radiographic progression -29% alternate 2l tx 
Chief Heme/Onc Education Fellow @MDAndersonNews | Alum of @dukeu @muschealth @vumchealth | Interest in #meded ??#cancer #lcsm | Tweets my own ? medical advice